Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Brooks-Kayal AR, Bath KG, Berg AT, Galanopoulou AS, Holmes GL, Jensen FE, Kanner AM, O'Brien TJ, Whittemore VH, Winawer MR, Patel M, Scharfman HE.

Epilepsia. 2013 Aug;54 Suppl 4:44-60. doi: 10.1111/epi.12298. Review.

2.

Epilepsy therapy development: technical and methodologic issues in studies with animal models.

Galanopoulou AS, Kokaia M, Loeb JA, Nehlig A, Pitkänen A, Rogawski MA, Staley KJ, Whittemore VH, Dudek FE.

Epilepsia. 2013 Aug;54 Suppl 4:13-23. doi: 10.1111/epi.12295. Review.

3.

[Emotional and behavioral comorbidities and the impact on the quality of life in epilepsy children].

Chen Q, Yan XX, Shang NX, Zhang GZ, Gao ZJ, Wang Y, Li EZ, Yang J, Xu KM.

Zhonghua Er Ke Za Zhi. 2010 May;48(5):346-50. Chinese.

PMID:
20654034
4.

Identification of new epilepsy treatments: issues in preclinical methodology.

Galanopoulou AS, Buckmaster PS, Staley KJ, Moshé SL, Perucca E, Engel J Jr, Löscher W, Noebels JL, Pitkänen A, Stables J, White HS, O'Brien TJ, Simonato M; American Epilepsy Society Basic Science Committee And The International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery.

Epilepsia. 2012 Mar;53(3):571-82. doi: 10.1111/j.1528-1167.2011.03391.x. Epub 2012 Jan 31. Review.

5.

Epilepsy and neuropsychological comorbidities.

Rudzinski LA, Meador KJ.

Continuum (Minneap Minn). 2013 Jun;19(3 Epilepsy):682-96. doi: 10.1212/01.CON.0000431382.06438.cd. Review.

PMID:
23739104
6.

[Psychogenic non epileptic seizures: a review].

Auxéméry Y, Hubsch C, Fidelle G.

Encephale. 2011 Apr;37(2):153-8. doi: 10.1016/j.encep.2010.04.009. Epub 2010 Jul 1. Review. French.

PMID:
21482234
7.

Psychiatric comorbidities in new onset epilepsy: Should they be always investigated?

Kanner AM.

Seizure. 2017 Jul;49:79-82. doi: 10.1016/j.seizure.2017.04.007. Epub 2017 Apr 14. Review.

PMID:
28532711
8.

Comorbidity between neurological illness and psychiatric disorders.

Hesdorffer DC.

CNS Spectr. 2016 Jun;21(3):230-8. doi: 10.1017/S1092852915000929. Epub 2016 Feb 22. Review.

PMID:
26898322
9.

Issues related to development of new antiseizure treatments.

Wilcox KS, Dixon-Salazar T, Sills GJ, Ben-Menachem E, White HS, Porter RJ, Dichter MA, Moshé SL, Noebels JL, Privitera MD, Rogawski MA.

Epilepsia. 2013 Aug;54 Suppl 4:24-34. doi: 10.1111/epi.12296. Review.

10.

The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder.

Hung CI, Wang SJ, Yang CH, Liu CY.

J Psychosom Res. 2008 Aug;65(2):135-42. doi: 10.1016/j.jpsychores.2008.04.011.

PMID:
18655858
11.

Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application.

Sheftell FD, Atlas SJ.

Headache. 2002 Oct;42(9):934-44.

PMID:
12390624
12.

Issues related to development of antiepileptogenic therapies.

Pitkänen A, Nehlig A, Brooks-Kayal AR, Dudek FE, Friedman D, Galanopoulou AS, Jensen FE, Kaminski RM, Kapur J, Klitgaard H, Löscher W, Mody I, Schmidt D.

Epilepsia. 2013 Aug;54 Suppl 4:35-43. doi: 10.1111/epi.12297. Review.

13.

The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understanding.

Pohlmann-Eden B, Aldenkamp A, Baker GA, Brandt C, Cendes F, Coras R, Crocker CE, Helmstaedter C, Jones-Gotman M, Kanner AM, Mazarati A, Mula M, Smith ML, Omisade A, Tellez-Zenteno J, Hermann BP.

Epilepsy Behav. 2015 Oct;51:199-209. doi: 10.1016/j.yebeh.2015.07.005. Epub 2015 Aug 24. Review.

PMID:
26291774
14.

Treatment of Cognitive Deficits in Epilepsy.

Leeman-Markowski BA, Schachter SC.

Neurol Clin. 2016 Feb;34(1):183-204. doi: 10.1016/j.ncl.2015.08.008. Review.

PMID:
26613999
15.

Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.

Rahman Z, Wong CH, Dexter M, Olsson G, Wong M, Gebsky V, Nahar N, Wood A, Byth K, King M, Bleasel AB.

Epilepsy Behav. 2015 Jul;48:88-95. doi: 10.1016/j.yebeh.2015.03.016. Epub 2015 Jun 29.

PMID:
26136184
16.

Interictal and postictal cognitive changes in migraine.

Mulder EJ, Linssen WH, Passchier J, Orlebeke JF, de Geus EJ.

Cephalalgia. 1999 Jul;19(6):557-65; discussion 541.

PMID:
10448542
17.

The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].

Sarkisova K, van Luijtelaar G.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):854-76. doi: 10.1016/j.pnpbp.2010.11.010. Epub 2010 Nov 17. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):212.

PMID:
21093520
18.

Behavioral and neuroendocrine assays for studying epilepsy-associated depression.

Mazarati A.

Epilepsia. 2013 Dec;54(12):2229. doi: 10.1111/epi.12397. No abstract available.

19.

Tourette syndrome, co-morbidities and quality of life.

Eapen V, Snedden C, Črnčec R, Pick A, Sachdev P.

Aust N Z J Psychiatry. 2016 Jan;50(1):82-93. doi: 10.1177/0004867415594429. Epub 2015 Jul 13.

PMID:
26169656
20.

Development of new treatment approaches for epilepsy: unmet needs and opportunities.

French JA, White HS, Klitgaard H, Holmes GL, Privitera MD, Cole AJ, Quay E, Wiebe S, Schmidt D, Porter RJ, Arzimanoglou A, Trinka E, Perucca E.

Epilepsia. 2013 Aug;54 Suppl 4:3-12. doi: 10.1111/epi.12294. Review.

Supplemental Content

Support Center